期刊
AMERICAN JOURNAL OF TRANSPLANTATION
卷 9, 期 4, 页码 687-696出版社
WILEY
DOI: 10.1111/j.1600-6143.2009.02553.x
关键词
Endothelial cell hyperpolarization; ischemia; reperfusion injury; K-ATP channels; neutrophil recruitment
资金
- Canadian Institutes of Health Research
- Kidney Foundation of Canada
- Heart and Stroke Foundation of Canada
- Alberta Heritage Foundation for Medical Research
- Heart and Stroke Foundation of Alberta and the Northwest Territories
Ischemia/reperfusion injury in renal transplantation leads to slow or initial nonfunction, and predisposes to acute and chronic rejection. In fact, severe ischemia reperfusion injury can significantly reduce graft survival, even with modern immunosuppressive agents. One of the mechanisms by which ischemia/reperfusion causes injury is activation of endothelial cells resulting in inflammation. Although several therapies can be used to prevent leukocyte recruitment to ischemic vessels (e.g. antiadhesion molecule antibodies), there have been no clinical treatments reported that can prevent initial immediate neutrophil recruitment upon reperfusion. Using intravital microscopy, we describe abrogation of immediate neutrophil recruitment to ischemic microvessels by the K-ATP antagonist glibenclamide (Glyburide (TM)). Further, we show that glibenclamide can reduce leukocyte recruitment in vitro under physiologic flow conditions. ATP-regulated potassium channels (K-ATP) are important in the control of cell membrane polarization. Here we describe profound hyperpolarization of endothelial cells during hypoxia, and the reduction of this hyperpolarization using glibenclamide. These findings suggest that control of endothelial membrane potential during ischemia may be an important therapeutic tool in avoiding ischemia/reperfusion injury, and therefore, enhancing transplant long-term function.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据